MOC Part II – LGBTQ+ Fact Versus Fiction (Dr. Scott Leibowitz)

When a Tanner IV adolescent presents in pediatric practice seeking gender affirming hormone therapy, according to the WPATH Standard of Care 8th edition, what is the most appropriate next step:

Prescribe GnRH agonist treatment

Prescribe the desired gender affirming hormone therapy

Obtain a comprehensive diagnostic assessment to understand treatment priorities.

Convince the patient they do not need hormones.

Refer the patient for spiritual counseling.

Which of the following is not associated with the use of puberty blockers for a young transgender adolescent?

Bone health monitoring

Linkage with a mental health provider during treatment

Genital growth in consideration of a possible future surgery

Tanner 1 pubertal staging at initiation of treatment

Time-limited duration of use in the absence of sex hormone exposure

Which of the following best characterizes the evidence-base for gender affirming care for adolescents?

The evidence-base is evolving, with some short-term and longitudinal data to support treatment.

There is a high degree of replicated longitudinal research.

There is very limited research to support any form of treatment.

It is unethical to move forward with irreversible treatments for minors.

Randomized control trials are underway and will provide more information regarding the safety of treatment.

Name

First

Last

Email

ABP Diplomate Number (required for ABP MOC Credit)

Date of Birth (required for ABP MOC Credit)